NSE to delist Deccan Chronicle, Koutons Retail, 17 othersNo Data Available
Ankur Drugs & Pharma Share Price
Loading...
| Open | - |
| High | 3.75 |
| Low | 3.65 |
| Prev Close | 3.65 |
| Volume | 10,260 |
| VWAP(₹) | - |
Stock not traded on NSE/BSE
Key Metrics
| PE Ratio(x) | - |
| EPS - TTM(₹) | - |
| MCap(₹ Cr.) | - |
| MCap Rank | - |
| PB Ratio(x) | - |
| Div Yield(%) | - |
| Face Value(₹) | - |
| 52W High(₹) | - |
| 52W Low(₹) | - |
| MCap/Sales | - |
| Beta(1 Month) | - |
| BV/Share(₹) | - |
Ankur Drugs & Pharma Ltd. share price insights
We don’t have any Insights for this stock currently.
Ankur Drugs & Pharma Ltd. Share Price Returns
| 1 Day | N.A. |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Ankur Drugs & Pharma Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Financials
Quarterly Dec 2012 Sep 2012 Jun 2012 Mar 2012 Dec 2011 Total Income 36.13 35.52 33.29 37.95 38.51 Total Income Growth (%) 1.70 6.72 -12.28 -1.45 14.93 Total Expenses 62.85 52.83 52.97 89.36 61.04 Total Expenses Growth (%) 18.96 -0.26 -40.73 46.40 2.38 EBIT -26.72 -17.31 -19.68 -51.41 -22.53 EBIT Growth (%) - - - - - Profit after Tax (PAT) -40.84 -23.47 -63.49 -119.55 -36.62 PAT Growth (%) - - - - - EBIT Margin (%) -73.95 -48.72 -59.12 -135.48 -58.51 Net Profit Margin (%) -113.04 -66.06 -190.74 -315.02 -95.11 Basic EPS (₹) -21.12 -12.13 -32.83 -61.81 -18.94 No Data Available
No Data Available
No Data Available
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Ankur Drugs & Pharma Ltd. Top Searches
Corporate Actions
Board Meeting
Quarterly Results & Others
May 20, 2013
General Meeting
(Cancelled)
May 08, 2013
Board Meeting
Quarterly Results
Feb 07, 2013
Announced on Meeting on May 20, 2013 May 25, 2013 Quarterly Results & Others Feb 07, 2013 Feb 14, 2013 Quarterly Results Nov 01, 2012 Nov 10, 2012 Quarterly Results Sep 24, 2012 Sep 29, 2012 Audited Results Aug 30, 2012 Sep 04, 2012 Audited Results Announced on Ex-Date Dividend% Sep 02, 2010 Sep 21, 2010 22% Sep 02, 2009 Sep 23, 2009 22% Aug 28, 2008 Sep 19, 2008 22% Nov 23, 2007 Dec 19, 2007 20% Sep 05, 2006 Sep 21, 2006 15% No Data Available
No Data Available
No Data Available
Announced on Meeting on May 08, 2013 May 22, 2013 (Cancelled) Nov 12, 2012 Dec 31, 2012 Book closure from Dec 24, 2012 to Dec 31, 2012 Mar 02, 2012 Mar 13, 2012 1. To increase in the Authorised Share Capital of the Company & Reclassification of Share Capital. 2. Alteration in the AoA of the Company. 3. Issue of 0.001% Optionally Convertible Cumulative Redeemable Preference Share on a prefential basis. Sep 12, 2011 Sep 30, 2011 Book closure from Sep 23, 2011 to Sep 30, 2011 Sep 02, 2010 Sep 30, 2010 Rs.2.25 per share(22.5%)Dividend
About Ankur Drugs & Pharma
Industry
Key Indices Listed On
-
Address
C-306, Crystal Plaza,Andheri Link Road,Andheri (W)Mumbai, Maharashtra - 400053
Executive Leadership
No Data Available
Auditors
No Data Available
Top Gainers
As on 03:57 PM | 19 Jun 2026Top Losers
As on 03:59 PM | 19 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.